Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
American College of Radiology Imaging Network
M.D. Anderson Cancer Center
Region Skane
Yale University
H. Lee Moffitt Cancer Center and Research Institute
Catharina Ziekenhuis Eindhoven
University of Kentucky
National Institutes of Health Clinical Center (CC)